Southwest Oncology Group 0408
Published
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , |
| التنسيق: | article |
| منشور في: |
2015
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/2540 http://dx.doi.org/10.3816/CCC.2006.n.015 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513458608799744 |
|---|---|
| author | Abdalla, Eddie |
| author2 | Eng, Cathy Madary, Alice Vauthey, Nicolas |
| author2_role | author author author |
| author_facet | Abdalla, Eddie Eng, Cathy Madary, Alice Vauthey, Nicolas |
| author_role | author |
| dc.creator.none.fl_str_mv | Abdalla, Eddie Eng, Cathy Madary, Alice Vauthey, Nicolas |
| dc.date.none.fl_str_mv | 2015-11-12T07:52:25Z 2015-11-12T07:52:25Z 2015-11-12 |
| dc.identifier.none.fl_str_mv | 1533-0028 http://hdl.handle.net/10725/2540 http://dx.doi.org/10.3816/CCC.2006.n.015 Abdalla, E. K., Eng, C., Madary, A., & Vauthey, J. N. (2006). Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clinical colorectal cancer, 5(6), 436-438. |
| dc.language.none.fl_str_mv | en |
| dc.relation.none.fl_str_mv | Clinical Colorectal Cancer |
| dc.rights.*.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.title.none.fl_str_mv | Southwest Oncology Group 0408 Phase II Trial of Neoadjuvant Capecitabine/Oxaliplatin/Bevacizumab for Resectable Colorectal Metastases in the Liver |
| dc.type.none.fl_str_mv | Article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/article |
| description | Published |
| eu_rights_str_mv | openAccess |
| format | article |
| id | LAURepo_b404c4d1b1561c91d8b6b8e4d55d6de0 |
| identifier_str_mv | 1533-0028 Abdalla, E. K., Eng, C., Madary, A., & Vauthey, J. N. (2006). Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clinical colorectal cancer, 5(6), 436-438. |
| language_invalid_str_mv | en |
| network_acronym_str | LAURepo |
| network_name_str | Lebanese American University repository |
| oai_identifier_str | oai:laur.lau.edu.lb:10725/2540 |
| publishDate | 2015 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| spelling | Southwest Oncology Group 0408Phase II Trial of Neoadjuvant Capecitabine/Oxaliplatin/Bevacizumab for Resectable Colorectal Metastases in the LiverAbdalla, EddieEng, CathyMadary, AliceVauthey, NicolasPublishedN/A2015-11-12T07:52:25Z2015-11-12T07:52:25Z2015-11-12Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1533-0028http://hdl.handle.net/10725/2540http://dx.doi.org/10.3816/CCC.2006.n.015Abdalla, E. K., Eng, C., Madary, A., & Vauthey, J. N. (2006). Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clinical colorectal cancer, 5(6), 436-438.enClinical Colorectal Cancerinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/25402019-02-26T11:10:19Z |
| spellingShingle | Southwest Oncology Group 0408 Abdalla, Eddie |
| status_str | publishedVersion |
| title | Southwest Oncology Group 0408 |
| title_full | Southwest Oncology Group 0408 |
| title_fullStr | Southwest Oncology Group 0408 |
| title_full_unstemmed | Southwest Oncology Group 0408 |
| title_short | Southwest Oncology Group 0408 |
| title_sort | Southwest Oncology Group 0408 |
| url | http://hdl.handle.net/10725/2540 http://dx.doi.org/10.3816/CCC.2006.n.015 |